Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dragonfly Therapeutics
BeOne Medicines
National Cancer Institute (NCI)
Genmab
Eli Lilly and Company
Wake Forest University Health Sciences
Jonsson Comprehensive Cancer Center
University of Iowa
Rutgers, The State University of New Jersey
Mayo Clinic
University of Southern California
BeiGene
Innovent Biologics (Suzhou) Co. Ltd.
Fox Chase Cancer Center
UNC Lineberger Comprehensive Cancer Center
ImmunityBio, Inc.
Purple Biotech Ltd.
Radiation Therapy Oncology Group
Merck Sharp & Dohme LLC
Vanderbilt-Ingram Cancer Center
University of Iowa
Guangdong Provincial People's Hospital
Guangdong Provincial People's Hospital
Albert Einstein College of Medicine
Wake Forest University Health Sciences
University of Nebraska
Eastern Cooperative Oncology Group
Guangdong Provincial People's Hospital
OHSU Knight Cancer Institute
Nektar Therapeutics
Shanghai Chest Hospital
NextCure, Inc.
University of Washington
Emory University
Kobe Minimally Invasive Cancer Center
National Cancer Institute (NCI)
Masonic Cancer Center, University of Minnesota
Ohio State University Comprehensive Cancer Center
Southwest Hospital, China
University of California, Davis
University of Washington
University of Washington
University of Washington
Case Comprehensive Cancer Center
Chipscreen Biosciences, Ltd.
National Cancer Institute (NCI)
University of Rochester
Virginia Commonwealth University